Menstrual Cycle Maintenance and Quality of Life: A Prospective Study
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Breast Cancer, Cancer, Women's Studies |
| Therapuetic Areas: | Oncology, Reproductive |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/5/2019 |
| Start Date: | December 1997 |
| End Date: | December 2019 |
Very little is known about the incidence, onset, time course, and symptomatology of premature
menopause induced by breast cancer therapy. No prospective study exists. The purpose of the
present study is to identify determinants of treatment-related amenorrhea nad its effect on
quality of life in a cohort of youg breast cancer patients.
menopause induced by breast cancer therapy. No prospective study exists. The purpose of the
present study is to identify determinants of treatment-related amenorrhea nad its effect on
quality of life in a cohort of youg breast cancer patients.
Inclusion Criteria:
- Non-institutional (community dwelling) woman of any race
- Between 18-45 years at the first screening visit
- Have regular menstrual cycles
- Diagnosed with invasive breast cancer stage I, II, III within the previous eight
months
- Have physician agreement for patient participation
Exclusion Criteria:
- No menstrual bleeding cycles
- Psychiatric or psychologic abnormality precluding the informed consent process or
which would decrease compliance
- Previous malignancy (excepting basal and squamous skin cancer and stage 0 cervical
cancer)
- Stage IV breast malignancy
- Residency outside United States
- No telephone
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
